Seroprevalence of SARS-CoV-2 antibodies among Forcibly Displaced Myanmar Nationals in Cox's Bazar, Bangladesh 2020: a population-based cross-sectional study. Issue 11 (21st November 2022)

• Record Type: Journal Article
• Authors: Rahman, Mahbubur; Khan, Samsad Rabbani; Alamgir, A S M; Kennedy, David S; Hakim, Ferdous; Evers, Egmond Samir; Afreen, Nawroz; Alam, Ahmed Nawsher; Islam, Md Sahidul; Paul, Debashish; Bhuiyan, Rijwan; Islam, Raisul; Moureen, Adneen; Salimuzzaman, M; Billah, Mallick Masum; Sharif, Ahmed Raihan; Akter, Mst Khaleda; Sultana, Sharmin; Khan, Manjur Hossain; von Harbou, Kai; Zaman, Mohammad Mostafa; Shirin, Tahmina; Flora, Meerjady Sabrina
• Is Part Of: BMJ open. Volume 12:Issue 11(2022)
• Publication Date: 2022-11-21
• Subjects: COVID-19 -- Epidemiology -- Public health -- EPIDEMIOLOGY -- PUBLIC HEALTH; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2022-066653
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objectives: The study aimed to determine the seroprevalence, the fraction of asymptomatic infections, and risk factors of SARS-CoV-2 infections among the Forcibly Displaced Myanmar Nationals (FDMNs). Design: It was a population-based two-stage cross-sectional study at the level of households. Setting: The study was conducted in December 2020 among household members of the FDMN population living in the 34 camps of Ukhia and Teknaf Upazila of Cox's Bazar district in Bangladesh. Participants: Among 860 697 FDMNs residing in 187 517 households, 3446 were recruited for the study. One individual aged 1 year or older was randomly selected from each targeted household. Primary and secondary outcome measures: Blood samples from respondents were tested for total antibodies for SARS-CoV-2 using Wantai ELISA kits, and later positive samples were validated by Kantaro kits. Results: More than half (55.3%) of the respondents were females, aged 23 median (IQR 14–35) years and more than half (58.4%) had no formal education. Overall, 2090 of 3446 study participants tested positive for SARS-CoV-2 antibody. The weighted and test adjusted seroprevalence (95% CI) was 48.3% (45.3% to 51.4%), which did not differ by the sexes. Children (aged 1–17 years) had a significantly lower seroprevalence 38.6% (95% CI 33.8% to 43.4%) compared with adults (58.1%, 95% CI 55.2% to 61.1%). Almost half (45.7%, 95% CI 41.9% to 49.5%) of seropositive individuals reported no relevant symptoms since March 2020. Antibody seroprevalence was higher in those with any comorbidity (57.8%, 95% CI 50.4% to 64.5%) than those without (47.2%, 95% CI 43.9% to 50.4%). Multivariate logistic regression analysis of all subjects identified increasing age and education as risk factors for seropositivity. In children (≤17 years), only age was significantly associated with the infection. Conclusions: In December 2020, about half of the FDMNs had antibodies against SARS-CoV-2, including those who reported no history of symptoms. Periodic serosurveys are necessary to recommend appropriate public health measures to limit transmission.